Keynote address: Modification of normal tissue response to radiotherapy and chemotherapy
- 1 May 1989
- journal article
- review article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 16 (5) , 1195-1200
- https://doi.org/10.1016/0360-3016(89)90282-4
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gainInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Protection by WR-2721 of human bone marrow function following irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Induction of hypoxia in normal and malignant tissues by changing the oxygen affinity of hemoglobin—Implications for theraphyInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Inhibition of the protective effect of cyclophosphamide by pre-treatment with buthionine sulfoximineInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Radioprotection by WR-2721 in vitro at low oxygen tensions: Implications for its mechanisms of actionBritish Journal of Cancer, 1983
- Early results of the screening program for radioprotectorsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Radioprotection of mouse skin by WR-2721: The critical influence of oxygen tensionInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Thiol radioprotectionin vivo: the critical role of tissue oxygen concentrationThe British Journal of Radiology, 1981
- Radiobiological and Biochemical Studies of Thiophosphate Radioprotective Compounds Related to CysteamineRadiation Research, 1971
- Blood flow and oxygenation of tumors in mice.II. Effects of vasodilator drugsCancer, 1967